retatrutide phase 3 2025 triple agonist glp-1 gip glucagon Retatrutide (40mg) What GLP‑3 Really Is: Retatrutide
Description
N Engl J Med 2024
Insulin resistance promotes ovarian androgen excess and disrupts folliculogenesis
The mortality risk associated with T2DM is only secondary to an increase in an individuals risk of acquiring other disease states that are both vascular and nonvascular in origin [1]
doi: 10.1111/j.1365-2125.2007.02890.x [DOI] [PMC free article] [PubMed] [Google Scholar] 74
